This follows recent reports showing that IL-1β and IL-18 production can provide protection against colitis, and supported by recent GWAS studies showing that the polymorphisms which confer hypofunctional NLRP3 phenotypes are associated with the development of IBD (125). Here, NLRP3 is linked to colitis.